Journal Guide

The Journal of Laboratory Medicine (JLM) is a bi-monthly published journal that reports on the latest developments in laboratory medicine. Particular focus is placed on the diagnostic aspects of the clinical laboratory, although technical, regulatory, and educational topics are equally covered. . The journal specializes in the publication of high-standard review articles on clinical, methodological and pathogenic aspects of modern laboratory diagnostics. These reviews are critically reviewed by JLM’s associate editors who are specialists in the various subdisciplines of laboratory medicine. In addition, JLM continues to publish original research articles, case reports and letters to the editor, all of which are peer reviewed by at least two experts in the field.

Better job prospects. Higher salaries. The respect of your colleagues. The confidence that comes from knowing you’re fully qualified to be a top-notch laboratory professional. Since 1928, certification by the ASCP Board of Certification (BOC) (formerly the ASCP Board of Registry) has been the industry standard for laboratory professionals.

Lipids in Health and Disease is ready to receive manuscripts on all aspects of lipids in health and disease.

Machine Learning: Health is a multidisciplinary open access journal dedicated to the application of machine learning, artificial intelligence (AI) and data-driven computational methods across healthcare and the medical, biological, clinical, and health sciences. The journal also publishes research that presents methodological, theoretical, or conceptual advances in machine learning and AI with applications to medicine and health sciences.

Materials Chemistry Frontiers is devoted to the publication of original contributions at the interface of chemistry and materials science, with topics spanning but not limited to energy materials, catalysis, biomaterials, nanoscience, polymers, luminescent materials, and sensors. The journal places an emphasis on original research that demonstrates conceptual advancements with emerging applications, rather than primarily reporting technological improvements. Together with Organic Chemistry Frontiers and Inorganic Chemistry Frontiers, this suite of journals offers an authoritative portfolio that is jointly owned by the Chinese Chemical Society, the Royal Society of Chemistry, and partner institutions.

Molecular Cytogenetics encompasses all aspects of chromosome biology and the application of molecular cytogenetic techniques in all areas of biomedicine.

Molecular Omics publishes high-quality research from across the -omics sciences that provide significant new insight into important chemical or biological problems. Topics covered by Molecular Omics include, but are not limited to, proteomics, genomics, transcriptomics, lipidomics, glycomics, metabolomics, microbiomics, sequencing technologies and bioinformatic research. Molecular Omics articles report research that significantly increases understanding or demonstrates clear functional benefits, supported by experimental validation or a novel data analytic approach. Topics include, but are not limited to: -omics studies to gain mechanistic insight into biological processes; -omics studies for clinical applications with experimental validation, such as finding biomarkers for diagnostics or potential new drug targets; -omics studies looking at the sub-cellular make-up of cells – for example, the subcellular localisation of certain proteins or post-translational modifications or new imaging techniques; studies presenting new methods and tools to support omics studies, including new spectroscopic/chromatographic techniques, chip-based/array technologies and new classification/data analysis techniques.

Organic Chemistry Frontiers is an international forum for cutting-edge research from all disciplines of organic chemistry, with topics spanning but not limited to organic synthesis, catalysis, natural products, functional organic materials, supramolecular and macromolecular chemistry, physical and computational chemistry, medicinal chemistry, and bioorganic chemistry. Emphases are placed on studies that make significant contributions to the field of organic chemistry by reporting either new or significantly improved protocols or methodologies. Together with Inorganic Chemistry Frontiers and Materials Chemistry Frontiers, this suite of journals offers an authoritative portfolio that is jointly owned by the Chinese Chemical Society, the Royal Society of Chemistry, and partner institutions.

Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews.Research Areas Include:• All major diseases of the lung• Physiology• Pathology• Drug delivery• Metabolism• Pulmonary ToxicologyBefore submitting, please note the "Rules of 5" defining immediate rejection criteria of PPT:1. Out of scope: The paper should report on the use of pharmacological or toxicological studies (positive or negative) that are directly related to Pulmonary Pharmacology & Therapeutics.Immediate rejection criteria are: a) Testing of extracts or plant parts that are not characterized b) Case Reports or n=1 studies2. Too preliminary: A paper must be based on a thorough and extensive study, using proper controlsImmediate rejection criteria are: a) In vitro studies with a single dose, or very high concentration b) Single dose studies with very few animals, no dose-response studies c) No proper controls. d) Repetition or confirmation of an earlier work3. Unethical: The study must have been carried under appropriate ethical approval for the study (either animal or human).4. Inappropriate experiments or lacking essential detailImmediate rejection criteria are: a) Wrong species or lacking details on the exact number of animals/subjects used b) No details of structure if a new drug is used for the first time5. Lack of novelty: The study must represent a novel approach to the field.Immediate rejection criteria are: a) Repetition of well known data b) No advance of knowledge in the fieldNote that only manuscripts written in good English will be considered by the Editors (British usage is preferred).